Kidney Research and Clinical Practice : eISSN 2211-9140 / pISSN 2211-9132

Cited by CrossRef (8)

  1. Raymond Vanholder, Steven Van Laecke, Griet Glorieux, Francis Verbeke, Esmeralda Castillo-Rodriguez, Alberto Ortiz. Deleting Death and Dialysis: Conservative Care of Cardio-Vascular Risk and Kidney Function Loss in Chronic Kidney Disease (CKD). Toxins 2018;10:237
    https://doi.org/10.3390/toxins10060237
  2. Ki Heon Nam, Hae-Ryong Yun, Young Su Joo, Joohwan Kim, Sangmi Lee, Changhyun Lee, Kyoung Sook Park, Jung Tak Park, Tae-Ik Chang, Ea Wha Kang, Tae-Hyun Yoo, Shin-Wook Kang, Seung Hyeok Han. Changes in obese metabolic phenotypes over time and risk of incident chronic kidney disease. Diabetes Obes Metab 2018;20:2778
    https://doi.org/10.1111/dom.13458
  3. Tomohisa Shibata, Yuki Nomura, Akitsugu Takada, Mai Ueno, Masataka Katashima, Rie Yazawa, Kenichi Furihata. Evaluation of Food and Spherical Carbon Adsorbent Effects on the Pharmacokinetics of Roxadustat in Healthy Nonelderly Adult Male Japanese Subjects. Clinical Pharmacology in Drug Development 2018
    https://doi.org/10.1002/cpdd.597
  4. Gerald Schulman, Tomas Berl, Gerald J. Beck, Giuseppe Remuzzi, Eberhard Ritz, Miho Shimizu, Mami Kikuchi, Yuko Shobu. Risk factors for progression of chronic kidney disease in the EPPIC trials and the effect of AST-120. Clin Exp Nephrol 2018;22:299
    https://doi.org/10.1007/s10157-017-1447-0
  5. Wen-Chih Liu, Yasuhiko Tomino, Kuo-Cheng Lu. Impacts of Indoxyl Sulfate and p-Cresol Sulfate on Chronic Kidney Disease and Mitigating Effects of AST-120. Toxins 2018;10:367
    https://doi.org/10.3390/toxins10090367
  6. Hideki Fujii, Shunsuke Goto, Masafumi Fukagawa. Role of Uremic Toxins for Kidney, Cardiovascular, and Bone Dysfunction. Toxins 2018;10:202
    https://doi.org/10.3390/toxins10050202
  7. Angelika Bazyluk, Jolanta Malyszko, Edyta Zbroch. Cardiovascular risk in chronic kidney disease: what is new in the pathogenesis and treatment?. Postgraduate Medicine 2018;130:461
    https://doi.org/10.1080/00325481.2018.1481714
  8. Suguru Yamamoto. Molecular mechanisms underlying uremic toxin-related systemic disorders in chronic kidney disease: focused on β2-microglobulin-related amyloidosis and indoxyl sulfate-induced atherosclerosis—Oshima Award Address 2016. Clin Exp Nephrol 2018
    https://doi.org/10.1007/s10157-018-1588-9